Skip to main content

Table 1 Cardiac function-related parameters in different groups \( \left(\overline{x}\pm \mathrm{s}\right) \)

From: Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

Group

N

Sham

Model

Danqi pill

Positive drug

LV Mass (ug)

12

647.29 ± 206.658**

936.29 ± 203.356

803.33 ± 213.294

872.65 ± 137.586

IVS;d (cm)

12

1.986 ± 0.316**

1.402 ± 0.378

1.532 ± 0.500

1.190 ± 0.380

IVS;s(cm)

12

2.915 ± 0.592 **

1.658 ± 0.684

2.050 ± 0.886

1.476 ± 0.539

LVEDd(cm)

12

5.735 ± 0.656**

8.741 ± 1.2054

7.777 ± 1.869

9.107 ± 1.138

LVED;s(cm)

12

2.988 ± 0.829 **

7.059 ± 1.535

5.746 ± 2.502*

7.538 ± 1.519

LVPWd(mm)

12

2.030 ± 0.441**

2.012 ± 0.389

1.953 ± 0.392

1.852 ± 0.361

LVPWs(mm)

12

2.758 ± 0.598**

2.792 ± 0.481

2.254 ± 0.618

2.560 ± 0.618

EF (%)

12

78.274 ± 10.514**

41.388 ± 17.238

52.375 ± 24.421**

34.823 ± 14.849

FS(%)

12

48.826 ± 10.557**

21.882 ± 10.552

30.241 ± 17.328**

17.905 ± 8.367

  1. *P < 0.05, **P < 0.01, Levels in the model group were used as reference to calculate P values.